Go Digit General Insurance invests Rs 30 crore in Dr Reddy’s Laboratories

Go Digit, which provides general insurance products to consumers, will receive a 0.32% stake in the company in exchange for the investment.

Agencies
Go Digit General Insurance has acquired a small stake in pharmaceuticals major Dr Reddy’s Laboratories through a cash infusion of Rs 30.06 crore, the insurance company said in a stock exchange filing today.

Go Digit, which offers general insurance products to consumers, will get a 0.32% stake in the company in lieu of the investment.

Incorporated back in 1984, Dr Reddy's Laboratories Ltd is a pharmaceutical company offering a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.


Go Digit’s investment in a pharma company comes at a time when PB Fintech, which runs insurance marketplace Policybazaar, has set up a subsidiary entity in healthcare services through PB Healthcare.

Dr Reddy’s Laboratories had closed the December quarter of the current financial year with total revenue of Rs 8,358 crore and a net profit of Rs 1,403 crore.

Go Digit General Insurance, which offers motor insurance, travel, health and other such products, ended the December quarter with total revenue of Rs 2,676 crore and a net profit of Rs 118 crore.
ADVERTISEMENT
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Tech › Funding › Go Digit General Insurance invests Rs 30 crore in Dr Reddy’s Laboratories
Text Size:AAA
Success
This article has been saved

*

+